United Therapeutics
In Howard Marks's portfolio · Oaktree Capital Management
Ticker UTHR.CV
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Oaktree Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2013 | Sell | 0 | |
| Q1 2013 | Buy | 37,610,000 | 1.0% |
| Q4 2012 | Sell | 0 | |
| Q3 2012 | Reduce 8% | 43,360,000 | 1.0% |
| Q2 2012 | Reduce 5% | 46,960,000 | 1.0% |
| Q1 2012 | First 13F | 49,460,000 | 0.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.